Cc1c(N(C(=O)c2ccccn2)C2(C(=O)NC3CCCC3)CCCCC2)c(=O)n(-c2ccccc2)n1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?